[Carcino-embryonic-antigen (CEA) in adenocarcinoma of uterine corpus (author's transl)].
Sandwich radio-immune assay was used before, parallel with as well as following surgical and radiation therapies on 73 patients in a follow-up check for an assessment of the clinical value of CEA im adenocarcinoma of the uterine corpus. CEA levels were increased in only 17 per cent of all cases. The strongest drops in CEA levels in correlation with patients' clinical response to therapy were recorded from those probands who had undergone surgery followed by Co60 irradiation. While CEA determination is, generally, recommended for monitoring of therapy and for the detection of recurrent corpus carcinomas, only pathological CEA levels should be considered as being relevant to clinical action, since the rate of false negative values has been as high as 34 per cent.
D000230:Adenocarcinoma / Q000601:surgery; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D003037:Cobalt Radioisotopes; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D014594:Uterine Neoplasms / Q000276:immunology* / Q000532:radiotherapy / Q000601:surgery
D002272:Carcinoembryonic Antigen; D003037:Cobalt Radioisotopes
Karzinoembryonales Antigen beim Endometriumkarzinom.